Alzheimer’s Blood Biomarker Diagnostics Market Driven by Early Detection Demand
The global blood-based biomarker for Alzheimer’s disease diagnostics market is experiencing significant growth as healthcare providers and researchers increasingly focus on early disease detection and improved patient management. Blood-based biomarkers are emerging as a transformative diagnostic tool by enabling less invasive, more accessible, and cost-effective screening compared to...
0 Yorumlar 0 hisse senetleri 21 Views 0 önizleme